Labor dystocia as First presentation of pelvic malignancy. by Hamont, D. van & Zusterzeel, P.L.M.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/98567
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
Hindawi Publishing Corporation
Case Reports in Obstetrics and Gynecology
Volume 2011, Article ID 584184, 2 pages
doi:10.1155/2011/584184
Case Report
Labor Dystocia as First Presentation of Pelvic Malignancy
Dennis van Hamont and Petra L. M. Zusterzeel
Department of Obstetrics and Gynecology, Radboud University Nijmegen Medical Centre, P.O. Box 9101,
6500 HB Nijmegen, The Netherlands
Correspondence should be addressed to Dennis van Hamont, d.vanhamont@obgyn.umcn.nl
Received 7 May 2011; Accepted 6 June 2011
Academic Editors: S. Becker, D. Ogunyemi, Y. Purwosunu, and S. Rasmussen
Copyright © 2011 D. van Hamont and P. L. M. Zusterzeel. This is an open access article distributed under the Creative Commons
Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
The underlying causes of labor dystocia can be various. Lack of expulsive forces or fetal malpresentation are amongst the most
common ones. However, pelvic masses are described as well. Here we describe two cases of labor dystocia as first presentation of
pelvic malignancy.
1. Introduction
Labor dystocia is responsible formore than 50 and 20 percent
of secondary cesarean sections in nulliparous women and
repeat cesareans, respectively [1]. Dystocia is considered the
result of (1) abnormalities of expulsive force; (2) abnormal-
ities of presentation, position, or development of the fetus;
(3) abnormalities of the maternal pelvis or birth canal; or
a combination of these factors [2]. Although infrequently
described, pelvic or intra-abdominal masses should be
contemplated as an underlying cause of obstructive delivery
and should be thought of especially after a normal vaginal
delivery in the past. We report two cases of labor dystocia as
first presentation of underlying pelvic malignancy.
Case 1. After an uncomplicated pregnancy a 32-year-old
G2P1 underwent a secondary cesarean section at GA 41
weeks for labor dystocia. Despite active support of labor
maximal cervical dilation measured 7 cm, her peripartum
medical record reported no abnormal findings. A healthy
daughter 3, 170 g was born. During surgery a large elastic to
solid abnormality was palpable in the anterior vaginal wall;
for no obvious reasons histology samples were not taken.
Her first pregnancy ended in a primary cesarean section
for breech presentation and preeclampsia at 37wks—giving
birth to a healthy son 2, 130 g. Further medical history
showed an appendectomy and a correction for inguinal her-
niation.
Four weeks after delivery patient was evaluated at an
outpatient clinic of a general nonteaching hospital for vaginal
discharge and fever. Again the mass in the anterior vagi-
nal wall was palpable. Vaginal cytological and histological
samples were taken but showed no evidence of abnormality.
The patient was treated with oral antibiotics (amoxicillin
with clavulanic acid) and reassessed 15 days later. At this
last visit the mass was still present but its consistency felt
rigid. Seven weeks postoperative a MRI-scan of the pelvis
showed a tumor 3.5 × 10 cm in the anterior vagina wall with
benign impression without any pathological lymph nodes
detectable.
Thereafter the patient was referred to our Gynecologic
Oncology Department of the Radboud University Nijmegen
Medical Centre (RUNMC), Nijmegen, The Netherlands.
Here she underwent an examination under anesthesia,
combined with a cystoscopy and obtainment of histology
samples. A rigid solid tumor was palpated in the ante-
rior vaginal wall reaching from the cervix to midurethral
extending laterally to the bilateral parametria. The trigone of
the urinary bladder was elevated. Since we suspected ureter
obstruction, ultrasonic evaluation of the kidneys followed,
showing a dilated left kidney and ureter. A true cut biopsy of
the anterior vaginal wall was taken.
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Histology of this biopsy revealed a diﬀuse large B-cell
non-Hodgkin lymphoma.
The left kidney function was restored by placing a
nephrostomy catheter. Patient was referred to the hema-
tology department for further evaluation and chemother-
apy treatment (R-CHOP; Rituximab, Cyclophosphamide,
Hydroxydaunorubicin (adriamycin), Oncovin (vincristine),
Prednisone). She showed a complete remission after eight R-
CHOP courses; also true cut biopsy revealed no evidence of
disease. However, since a reduced mass was still visible on
CT-scan adjuvant brachytherapy was initiated.
Case 2. A second patient was a 38-year-old G6P2 who under-
went a secondary cesarean section which was performed for
labor dystocia at GA 41 weeks. Her medical history revealed
a secondary cesarean for fetal distress and a vaginal delivery.
Both children were full-term and healthy.
The pregnancy was complicated by recurrent vaginal
blood loss in the second half, without any macroscopic
cervical abnormalities seen at gynecologic examination.
Cervical cytology at 27-week gestational age showed atypical
squamous cells of undetermined significance, and the smear
was scheduled to be repeated 6 weeks after delivery. The cur-
rent delivery was induced for oligohydramnios. The cervix
dilated to a maximum of 4 cm, despite good contractions.
The cervix felt firm to hard in consistency. After the cesarean
section histology samples of the cervix were taken in the same
theatre session, showing grade 2 squamous cell carcinoma
(SCC). She delivered a healthy son, 4,084 g.
After the diagnosis of SCC of the cervix, she was referred
to our Gynecologic Oncology Department (RUNMC) and
underwent an examination under anesthesia, revealing
a severely altered cervix with a tumor measuring 5 cm
involving the right parametrium. She was clinically staged
as a cervical cancer FIGO stage IIb. CT-scan showed no
pathological lymph nodes, but due to the short postpartum
interval the uterine cervix could not be assessed reliably.
Since delivery by cesarean section might have led to spill
of tumor cells intra-abdominally or might have provoked
hematological metastasis, the patient received 6 courses
neoadjuvant chemotherapy consisting of cisplatinum and
placitaxel, both 70mg/m2. Examination under anesthe-
sia after chemotherapy showed a substantial decrease in
tumor size to 1.5 cm. Patient was scheduled for radical
hysterectomy, bilateral salpingo-ooferectomy, and bilateral
pelvic lymphadenectomy. Histopathological analysis of the
specimens showed no further malignancy; all 18 removed
pelvic lymph nodes were negative for malignancy.
2. Discussion
Cervicovaginal, intraabdominal, or retroperitoneal abnor-
malities obstructing labor have been described since one
of the first publications by Freeth in 1950 [3]. These
abnormalities can be both benign [4–6] or malignant [7–9].
In the Netherlands cancer is among the leading causes of
nonaccidental death in young women, with mortality rates
of 26% in women aged 20 to 30 years and 42.5% aged 30 to
40 years [10]. Therefore, it is not surprising that an estimated
1 in 1000 women is aﬀected by cancer in pregnancy [11]. This
rate may further increase due to the tendency of postponing
pregnancy to the latter reproductive years.
Gynecologic malignancies associated with pregnancy can
be detected and diagnosed throughout pregnancy. However,
most gynecological cancers are found in the first and
second trimester of gravidity. Recurrent vaginal blood loss
or abnormal findings on prenatal ultrasound screening may
lead to early diagnosis. Adequate and repeated pelvic exam-
ination throughout routine antenatal care may detect pelvic
masses at an early stage. This might reduce obstructed and
complicated deliveries, but more importantly it may prevent
late complications due to metastatic disease [12]. Early
diagnosis and treatment is also important since significantly
better survival is observed in patients in whom cancer was
detected in early pregnancy [11].
As a result of frequent antenatal examination, obstructive
labor is seldom the first presentation of a pelvic malignancy.
However, it still occurs, and pelvic malignancy obstructing
labor should be considered peripartally in case of dystocia.
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